NSE - Free Realtime Quote INR

Poly Medicure Limited (POLYMED.NS)

1,637.95 +53.90 (+3.41%)
As of 11:53 AM GMT+5:30. Market Open.
Loading Chart for POLYMED.NS
DELL
  • Previous Close 1,584.05
  • Open 1,597.00
  • Bid --
  • Ask --
  • Day's Range 1,589.00 - 1,665.90
  • 52 Week Range 945.00 - 1,729.00
  • Volume 52,650
  • Avg. Volume 88,163
  • Market Cap (intraday) 157.196B
  • Beta (5Y Monthly) 0.34
  • PE Ratio (TTM) 63.05
  • EPS (TTM) 25.98
  • Earnings Date May 7, 2024 - May 11, 2024
  • Forward Dividend & Yield 3.00 (0.19%)
  • Ex-Dividend Date Sep 21, 2023
  • 1y Target Est 465.00

Poly Medicure Limited manufactures and sells medical devices in India and internationally. It offers infusion devices, such as I.V. cannulas, mid line catheters, arterial cannula, three way stop cocks, I.V. infusion sets, manifolds, safety winged infusion sets, T-type extension sets, stylet/mandrin with luer locks, vial access spikes, measured volume fluid administration sets, extension lines, central venous catheters, CVP manometers, needle free connectors, pre filled syringes, vascular accesses, and blood administration sets. The company also provides nasogastric and infant feeding tubes, gastro-duodenal feeding tubes, and umbilical catheters; urine collection bags, foley balloon catheters, irrigation sets, urine drainage catheters, and urine collection bags with measured volume meters; and endotracheal and tracheostomy tubes, mucus extractors, ventilator circuits, bain circuits, catheter mounts, spinal needles, HME filters, and laryngeal mask airways. It offers oncology products; endo bronchial suction catheters, oxygen catheters, respiratory exercisers, nasal oxygen cannulas, oro-pharyngeal airways, variable concentration masks, oxygen mask with reservoirs, fixed concentration masks, and aerosol therapy masks; and dialyzers, blood lines, dialysis systems, fistula needles, haemodialysis catheters, and peritoneal dialysis and transfusion sets. The company provides closed wound suction units, under water seal drainage systems, high pressure vacuum bottles, yankauer suction sets, and thoracic drainage catheters; blood collection tubes, safety blood collection sets, blood collection needles, ESR pipettes, and luer adaptors; blood bag systems; face protective shields, polymasks, and viral transport medium kits; and insulin syringes, sputum collectors, dry brushes, umbilical cord clamps, luer locks, cannula fixators, injection stoppers, luer lock injection sites, universal caps, and ECG electrodes. The company was incorporated in 1995 and is based in New Delhi, India.

www.polymedicure.com

2,339

Full Time Employees

March 31

Fiscal Year Ends

Related News

Performance Overview: POLYMED.NS

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

POLYMED.NS
9.94%
S&P BSE SENSEX
2.75%

1-Year Return

POLYMED.NS
69.42%
S&P BSE SENSEX
23.44%

3-Year Return

POLYMED.NS
61.13%
S&P BSE SENSEX
55.03%

5-Year Return

POLYMED.NS
736.90%
S&P BSE SENSEX
91.64%

Compare To: POLYMED.NS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: POLYMED.NS

Valuation Measures

Annual
As of 4/26/2024
  • Market Cap

    151.09B

  • Enterprise Value

    149.50B

  • Trailing P/E

    61.16

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    11.72

  • Price/Book (mrq)

    11.36

  • Enterprise Value/Revenue

    11.52

  • Enterprise Value/EBITDA

    37.40

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    19.07%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    13.05B

  • Net Income Avi to Common (ttm)

    2.49B

  • Diluted EPS (ttm)

    25.98

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.8B

  • Total Debt/Equity (mrq)

    10.10%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: POLYMED.NS

Analyst Price Targets

465.00 Low
465.00 Average
1,637.95 Current
465.00
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Company Insights: POLYMED.NS

People Also Watch